Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Losing with with diabetes is not easy but not impossible too. Here is a basic routine to burn calories with glucose level in ...

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...

GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...